Evidence map›Paper›PMID 35712095›Full record

ArticleFrontiers in medicine2022

Long-Term Kidney Prognosis and Pathological Characteristics of Late-Onset Lupus Nephritis.

Na Tian, Qian Zhou, PeiRan Yin, WenFang Chen, LingYao Hong, QiMei Luo, MengHua Chen, XueQing Yu, Wei Chen

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03001973 (High Quality Evidence of Chinese Lupus Nephritis), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03001973 recruitingnot on this map

High Quality Evidence of Chinese Lupus Nephritis (HELP)

TypeobservationalSponsorSun Yat-sen UniversityRan2013 to 2026Enrolled5,000ConditionsLupus NephritisArmsNo Intervention
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Late-onset lupus nephritis: what is the evidence?Kidney research and clinical practice · 2025
    Article
  4. Article
  5. Review
  6. Sex differences in mortality among patients with lupus nephritis.European journal of medical research · 2024
    Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Na TianKey Laboratory of National Health Commission, Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.
Qian ZhouKey Laboratory of National Health Commission, Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.
PeiRan YinKey Laboratory of National Health Commission, Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.
WenFang ChenDepartment of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
LingYao HongKey Laboratory of National Health Commission, Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.
QiMei LuoKey Laboratory of National Health Commission, Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.
MengHua ChenDepartment of Nephrology, General Hospital of Ningxia Medical University, Ningxia, China.
XueQing YuGuangdong Provincial People's Hospital, Guangzhou, China.
Wei ChenKey Laboratory of National Health Commission, Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Arguments still exist on prognosis of late-onset SLE, especially their kidney function. The purpose of this study was to investigate long-term kidney outcomes in patients with late-onset lupus nephritis (LN). Methods: A retrospective long-term cohort study was conducted in adult Chinese patients with LN. The patients were divided into late- (>50 years) and early-onset (<50 years) LN groups. The baseline characteristics, especially the kidney pathological characteristics, were compared. The cohort was followed-up for kidney outcome defined as doubling of serum creatinine or ESRD. Cox regression analysis was used to examine the association between late onset LN and its outcomes. Results: A total of 1,264 patients were recruited, who were assigned to late-onset LN with 102 patients and early-onset LN with 1,162 patients. The late-onset LN group showed a worse baseline kidney function and more chronic pathological lesions than the early-onset LN group. During a follow-up time of 55 (3, 207) months, 114 (13.1%) deaths occurred, 107 (12.2%) had doubling of creatinine, and 80 (9.1%) developed end-stage kidney disease. The 5- and 10-year survival rates of the late-onset LN group were 67.6 and 50.5%, respectively, which were much worse than those of the early-onset LN group (89.8 and 84.6%, respectively). However, no significant difference was found on kidney survival (log-rank chi-square = 3.55, Conclusions: Patients with late-onset LN had milder active lesions but severer chronic lesions in kidney pathology. They have poorer overall outcome but relatively favorable kidney outcome. Trial Registration: ClinicalTrials.gov Identifier: NCT03001973, 22 December 2016 retrospectively registered.

Indexed as

Chinese populationkidney outcomelate-onsetlupus nephritisrenal pathology

Identifiers

PMID35712095
PMCPMC9197116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.